BioSpectrum Asia

Industry 4.0 meets pharma


● In 2022, Triastek’s and Siemens China signed a collaborat­ion agreement to provide digital technologi­es for the global pharmaceut­ical industry. Combining Triastek’s 3D printing and digital pharmaceut­ical technologi­es and Siemens’ expertise in automation and digitisati­on is expected to lead to innovative and transforma­tive solutions for the developmen­t and manufactur­ing of pharmaceut­icals

● In 2022, Singapore’s MiRXES opened

Southeast Asia’s first industry 4.0 IVD (in vitro diagnostic­s) manufactur­ing facility in Singapore

● In 2021, UK’s GlaxoSmith­Kline is one of the first pharmaceut­ical companies to announce a digital twin initiative. Partnering with

Siemens and Atos, GSK has created a real-time simulation of the entire vaccine manufactur­ing process

● In 2021, Boehringer Ingelheim announced it is rolling out cutting-edge tech at the Vienna plant, from virtual reality and automation to digital twins and artificial intelligen­ce.

● In 2020, US’ Merck teamed up with Siemens to digitise its manufactur­ing processes with the objective to automate its modular production and advance pharma’s 4.0 movement

● In 2019, India based ACG Group opened industry 4.0 centre of excellence in Switzerlan­d

Newspapers in English

Newspapers from India